SOPHiA GENETICS - רווח למניה לשנה מתגלגלת SOPH

SOPHiA GENETICS SA (SOPH) is a recognized global authority in AI-driven bioinformatics, whose precision diagnostic solutions are highly valued by clinicians. This chart on GURU.Markets illustrates the EPS TTM dynamics, which currently stands at 2.10. Growth is driven by the expansion of its cloud service through a network of medical centers, while the high accuracy of its algorithms ensures business resilience against competitors.

Year-over-year EPS growth (TTM) measures the dynamics of net income per share over a rolling twelve-month period. This calculation allows for an assessment of the actual recovery speed of cash flows by excluding seasonal fluctuations. Analyzing the annual growth of basic net income per share (TTM) reveals the business's resilience to crises. For SOPHiA GENETICS SA (SOPH), recurring payments for cloud-based genome analysis ensure the predictability of this metric.